{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:23:26Z","timestamp":1794486206974,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The Ministry of Health, Labour, and Welfare of Japan","award":["16H05366"],"award-info":[{"award-number":["16H05366"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1521-3","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T12:34:55Z","timestamp":1518006895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells"],"prefix":"10.1186","volume":"20","author":[{"given":"Ryosuke","family":"Saigusa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trojanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"issue":"5","key":"1521_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","volume":"37","author":"Y Asano","year":"2015","unstructured":"Asano Y, Sato S. Vasculopathy in scleroderma. Semin Immunopathol. 2015;37(5):489\u2013500.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"1521_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","volume":"135","author":"KG MacDonald","year":"2015","unstructured":"MacDonald KG, Dawson NA, Huang Q, Dunne JV, Levings MK, Broady R. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis. J Allergy Clin Immunol. 2015;135(4):946\u201355.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1521_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","volume":"162","author":"E Antiga","year":"2010","unstructured":"Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A, Osella-Abate S, De Simone C, Marzano A, Bernengo MG, et al. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol. 2010;162(5):1056\u201363.","journal-title":"Br J Dermatol"},{"issue":"7","key":"1521_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","volume":"71","author":"A Mathian","year":"2012","unstructured":"Mathian A, Parizot C, Dorgham K, Trad S, Arnaud L, Larsen M, Miyara M, Hie M, Piette JC, Frances C, et al. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Ann Rheum Dis. 2012;71(7):1227\u201334.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1521_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","volume":"261","author":"G Slobodin","year":"2010","unstructured":"Slobodin G, Ahmad MS, Rosner I, Peri R, Rozenbaum M, Kessel A, Toubi E, Odeh M. Regulatory T cells (CD4+CD25brightFoxP3+) expansion in systemic sclerosis correlates with disease activity and severity. Cell Immunol. 2010;261(2):77\u201380.","journal-title":"Cell Immunol"},{"issue":"8","key":"1521_CR6","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/ard.2009.116525","volume":"70","author":"S Klein","year":"2011","unstructured":"Klein S, Kretz CC, Ruland V, Stumpf C, Haust M, Hartschuh W, Hartmann M, Enk A, Suri-Payer E, Oberle N, et al. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma. Ann Rheum Dis. 2011;70(8):1475\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1521_CR7","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","volume":"186","author":"SA McClymont","year":"2011","unstructured":"McClymont SA, Putnam AL, Lee MR, Esensten JH, Liu W, Hulme MA, Hoffmuller U, Baron U, Olek S, Bluestone JA, et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol. 2011;186(7):3918\u201326.","journal-title":"J Immunol"},{"issue":"4","key":"1521_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","volume":"25","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld M, Hafler DA. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol. 2013;25(4):305\u201312.","journal-title":"Semin Immunol"},{"issue":"14","key":"1521_CR9","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","volume":"121","author":"AM Pesenacker","year":"2013","unstructured":"Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, Wedderburn LR. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood. 2013;121(14):2647\u201358.","journal-title":"Blood"},{"key":"1521_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.biocel.2015.06.004","volume":"67","author":"Y Asano","year":"2015","unstructured":"Asano Y. Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis. Int J Biochem Cell Biol. 2015;67:86\u201391.","journal-title":"Int J Biochem Cell Biol"},{"key":"1521_CR11","first-page":"281","volume":"338","author":"KK Wu","year":"2006","unstructured":"Wu KK. Analysis of protein-DNA binding by streptavidin-agarose pulldown. Methods Mol Biol. 2006;338:281\u201390.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1521_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1346-8138.13156","volume":"43","author":"M Hasegawa","year":"2016","unstructured":"Hasegawa M. Biomarkers in systemic sclerosis: their potential to predict clinical courses. J Dermatol. 2016;43(1):29\u201338.","journal-title":"J Dermatol"},{"issue":"2","key":"1521_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/art.38948","volume":"67","author":"T Taniguchi","year":"2015","unstructured":"Taniguchi T, Asano Y, Akamata K, Noda S, Takahashi T, Ichimura Y, Toyama T, Trojanowska M, Sato S. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice. Arthritis Rheum. 2015;67(2):517\u201326.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1521_CR14","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","volume":"176","author":"Y Asano","year":"2010","unstructured":"Asano Y, Stawski L, Hant F, Highland K, Silver R, Szalai G, Watson DK, Trojanowska M. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol. 2010;176(4):1983\u201398.","journal-title":"Am J Pathol"},{"issue":"5","key":"1521_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L van Bon","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014;370(5):433\u201343.","journal-title":"N Engl J Med"},{"issue":"8","key":"1521_CR16","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1136\/annrheumdis-2015-207483","volume":"75","author":"E Romano","year":"2016","unstructured":"Romano E, Chora I, Manetti M, Mazzotta C, Rosa I, Bellando-Randone S, Blagojevic J, Soares R, Avouac J, Allanore Y, et al. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis. Ann Rheum Dis. 2016;75(8):1541\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1521_CR17","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1038\/ncomms6797","volume":"5","author":"S Noda","year":"2014","unstructured":"Noda S, Asano Y, Nishimura S, Taniguchi T, Fujiu K, Manabe I, Nakamura K, Yamashita T, Saigusa R, Akamata K, et al. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat Commun. 2014;5:5797.","journal-title":"Nat Commun"},{"issue":"5","key":"1521_CR18","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/art.39062","volume":"67","author":"K Akamata","year":"2015","unstructured":"Akamata K, Asano Y, Yamashita T, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Trojanowska M, Sato S. Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability. Arthritis Rheum. 2015;67(5):1335\u201344.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1521_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/bjd.14183","volume":"174","author":"R Saigusa","year":"2016","unstructured":"Saigusa R, Asano Y, Yamashita T, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Miyagaki T, Sugaya M, et al. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions. Br J Dermatol. 2016;174(2):338\u201347.","journal-title":"Br J Dermatol"},{"key":"1521_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-62703-481-4_8","volume":"1031","author":"CB Moore","year":"2013","unstructured":"Moore CB, Allen IC. Primary ear fibroblast derivation from mice. Methods Mol Biol. 2013;1031:65\u201370.","journal-title":"Methods Mol Biol"},{"issue":"Suppl 1","key":"1521_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jth.12247","volume":"11","author":"EA Bouwens","year":"2013","unstructured":"Bouwens EA, Stavenuiter F, Mosnier LO. Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway. J Thromb Haemost. 2013;11(Suppl 1):242\u201353.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1521_CR22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.ajpath.2010.11.055","volume":"178","author":"DA Pociask","year":"2011","unstructured":"Pociask DA, Chen K, Choi SM, Oury TD, Steele C, Kolls JK. \u03b3\u03b4 T cells attenuate bleomycin-induced fibrosis through the production of CXCL10. Am J Pathol. 2011;178(3):1167\u201376.","journal-title":"Am J Pathol"},{"issue":"4","key":"1521_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","volume":"306","author":"Y Ichimura","year":"2014","unstructured":"Ichimura Y, Asano Y, Akamata K, Takahashi T, Noda S, Taniguchi T, Toyama T, Aozasa N, Sumida H, Kuwano Y, et al. Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis. Arch Dermatol Res. 2014;306(4):331\u20138.","journal-title":"Arch Dermatol Res"},{"issue":"11","key":"1521_CR24","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1002\/art.34643","volume":"64","author":"Y Okamoto","year":"2012","unstructured":"Okamoto Y, Hasegawa M, Matsushita T, Hamaguchi Y, Huu DL, Iwakura Y, Fujimoto M, Takehara K. Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum. 2012;64(11):3726\u201335.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1521_CR25","doi-asserted-by":"publisher","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","volume":"4","author":"TR Radstake","year":"2009","unstructured":"Radstake TR, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, Deng Y, Simms R, Lubberts E, Lafyatis R. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGF\u03b2 and IFN\u03b3 distinguishes SSc phenotypes. PLoS One. 2009;4(6):e5903.","journal-title":"PLoS One"},{"issue":"12","key":"1521_CR26","first-page":"2628","volume":"26","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto T, Takahashi Y, Takagawa S, Katayama I, Nishioka K. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W\/W(V) mice. J Rheumatol. 1999;26(12):2628\u201334.","journal-title":"J Rheumatol"},{"issue":"11","key":"1521_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s004030000183","volume":"292","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto T, Kuroda M, Nishioka K. Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains. Arch Dermatol Res. 2000;292(11):535\u201341.","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"1521_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1523-1747.2003.12308.x","volume":"121","author":"S Takagawa","year":"2003","unstructured":"Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J. Sustained activation of fibroblast transforming growth factor-\u03b2\/Smad signaling in a murine model of scleroderma. J Invest Dermatol. 2003;121(1):41\u201350.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1521_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/exd.12076","volume":"22","author":"J Seltmann","year":"2013","unstructured":"Seltmann J, Werfel T, Wittmann M. Evidence for a regulatory loop between IFN-\u03b3 and IL-33 in skin inflammation. Exp Dermatol. 2013;22(2):102\u20137.","journal-title":"Exp Dermatol"},{"issue":"7090","key":"1521_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235\u20138.","journal-title":"Nature"},{"issue":"11","key":"1521_CR31","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.4049\/jimmunol.178.11.6725","volume":"178","author":"L Xu","year":"2007","unstructured":"Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25\u2212Foxp3\u2212 T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-\u03b2. J Immunol. 2007;178(11):6725\u20139.","journal-title":"J Immunol"},{"issue":"1","key":"1521_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1346-8138.2009.00764.x","volume":"37","author":"T Yamamoto","year":"2010","unstructured":"Yamamoto T. Animal model of systemic sclerosis. J Dermatol. 2010;37(1):26\u201341.","journal-title":"J Dermatol"},{"issue":"8","key":"1521_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00403-005-0635-z","volume":"297","author":"T Yamamoto","year":"2006","unstructured":"Yamamoto T. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis? Arch Dermatol Res. 2006;297(8):333\u201344.","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"1521_CR34","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"JH Korn","year":"2004","unstructured":"Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 2004;50(12):3985\u201393.","journal-title":"Arthritis Rheum"},{"issue":"24","key":"1521_CR35","doi-asserted-by":"publisher","first-page":"20839","DOI":"10.1074\/jbc.M010133200","volume":"276","author":"J Czuwara-Ladykowska","year":"2001","unstructured":"Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem. 2001;276(24):20839\u201348.","journal-title":"J Biol Chem"},{"issue":"12","key":"1521_CR36","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/art.39312","volume":"67","author":"Y Ichimura","year":"2015","unstructured":"Ichimura Y, Asano Y, Akamata K, Noda S, Taniguchi T, Takahashi T, Toyama T, Tada Y, Sugaya M, Sato S, et al. Progranulin overproduction due to Fli-1 deficiency contributes to the resistance of dermal fibroblasts to tumor necrosis factor in systemic sclerosis. Arthritis Rheum. 2015;67(12):3245\u201355.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1521_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","volume":"27","author":"S Sato","year":"2001","unstructured":"Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci. 2001;27(2):140\u20136.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"1521_CR38","first-page":"275","volume":"33","author":"T Matsushita","year":"2006","unstructured":"Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol. 2006;33(2):275\u201384.","journal-title":"J Rheumatol"},{"issue":"6","key":"1521_CR39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/08830180802430974","volume":"27","author":"RK Bhogal","year":"2008","unstructured":"Bhogal RK, Bona CA. Regulatory effect of extracellular signal-regulated kinases (ERK) on type I collagen synthesis in human dermal fibroblasts stimulated by IL-4 and IL-13. Int Rev Immunol. 2008;27(6):472\u201396.","journal-title":"Int Rev Immunol"},{"key":"1521_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vph.2015.07.012","volume":"73","author":"M Chalubinski","year":"2015","unstructured":"Chalubinski M, Wojdan K, Luczak E, Gorzelak P, Borowiec M, Gajewski A, Rudnicka K, Chmiela M, Broncel M. IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms. Vasc Pharmacol. 2015;73:57\u201363.","journal-title":"Vasc Pharmacol"},{"issue":"7","key":"1521_CR41","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","volume":"71","author":"K Khan","year":"2012","unstructured":"Khan K, Xu S, Nihtyanova S, Derrett-Smith E, Abraham D, Denton CP, Ong VH. Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis. Ann Rheum Dis. 2012;71(7):1235\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1521_CR42","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1186\/ar4672","volume":"16","author":"L Desallais","year":"2014","unstructured":"Desallais L, Avouac J, Frechet M, Elhai M, Ratsimandresy R, Montes M, Mouhsine H, Do H, Zagury JF, Allanore Y. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis. Arthritis Res Ther. 2014;16(4):R157.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1521_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","volume":"29","author":"XO Yang","year":"2008","unstructured":"Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29(1):44\u201356.","journal-title":"Immunity"},{"issue":"11","key":"1521_CR44","doi-asserted-by":"publisher","first-page":"7708","DOI":"10.4049\/jimmunol.175.11.7708","volume":"175","author":"Y Asano","year":"2005","unstructured":"Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Increased expression of integrin \u03b1v\u03b23 contributes to the establishment of autocrine TGF-\u03b2 signaling in scleroderma fibroblasts. J Immunol. 2005;175(11):7708\u201318.","journal-title":"J Immunol"},{"issue":"9","key":"1521_CR45","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1002\/art.21246","volume":"52","author":"Y Asano","year":"2005","unstructured":"Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Involvement of \u03b1v\u03b25 integrin-mediated activation of latent transforming growth factor \u03b21 in autocrine transforming growth factor \u03b2 signaling in systemic sclerosis fibroblasts. Arthritis Rheum. 2005;52(9):2897\u2013905.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1521_CR46","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","volume":"185","author":"A Yoshizaki","year":"2010","unstructured":"Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Akiyama Y, Muroi E, Hara T, Ogawa F, Takenaka M, et al. Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol. 2010;185(4):2502\u201315.","journal-title":"J Immunol"},{"issue":"5 Suppl 100","key":"1521_CR47","first-page":"14","volume":"34","author":"L Lei","year":"2016","unstructured":"Lei L, Zhao C, Qin F, He ZY, Wang X, Zhong XN. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Clin Exp Rheumatol. 2016;34(5 Suppl 100):14\u201322.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1521_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","volume":"76","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Hou W, Xu K, Han D, Jiang C, Mou K, Li Y, Meng L, Lu S. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis. Hum Immunol. 2015;76(1):22\u20139.","journal-title":"Hum Immunol"},{"issue":"1","key":"1521_CR49","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/ar4430","volume":"16","author":"X Yang","year":"2014","unstructured":"Yang X, Yang J, Xing X, Wan L, Li M. Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction. Arthritis Res Ther. 2014;16(1):R4.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1521_CR50","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","volume":"50","author":"M Murata","year":"2008","unstructured":"Murata M, Fujimoto M, Matsushita T, Hamaguchi Y, Hasegawa M, Takehara K, Komura K, Sato S. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci. 2008;50(3):240\u20132.","journal-title":"J Dermatol Sci"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1521-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:51:12Z","timestamp":1549500672000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1521-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1521-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee and the committee on animal experimentation of the University of Tokyo Graduate School of Medicine. Human normal dermal fibroblasts were purchased and used; therefore, consent to participate was not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"23"}}